Skip to content
healthcare.dev

Mycapssa

NDC 10122-550, Octreotide, capsule, delayed release, from Chiesi USA, Inc..

Product NDC
10122-550
Status
Listed
Labeler
Chiesi USA, Inc.
Dosage form
CAPSULE, DELAYED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA208232
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/10122-550 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OCTREOTIDE20 mg/1

Pharmacologic classes

Somatostatin Analog [EPC]; Somatostatin Receptor Agonists [MoA]

Package NDCNDC-11Package
10122-550-28101220550284 BLISTER PACK in 1 DOSE PACK (10122-550-28) / 7 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/58d80bc6-bdfb-4908-93e7-aace447c8d1a

Use it

Look up 10122-550 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/10122-550 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 10122-550. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.